The International Society of Gastrointestinal Oncology (ISGIO) has named Howard Hochster, MD, as president elect. Hochster, Professor of Medical Oncology; Associate Director for Clinical Sciences at Yale Cancer Center; and Director of the Gastrointestinal Cancers Program at Smilow Cancer Hospital at Yale-New Haven, will serve a two-year term as president-elect followed by two years as president.
ISGIO is a unique society dedicated to a high level of research and education in gastrointestinal cancers. The organization’s goals are to promote timely dissemination of the most current knowledge in research and treatment of GI cancers globally and to educate young experts. The recent meeting of ISGIO featured lectures by experts from Europe and Asia as well as the United States and presentations by fellows training in the field.
Hochster is an internationally-known expert in cancer clinical trials and early drug development, particularly in gastrointestinal cancer. He joined the Yale faculty in 2010 as YCC Associate Director and Director of GI Oncology. He has published widely on treatment of colon, pancreatic and gastric cancer and has been in the forefront of developing newer chemotherapy and targeted agents for these diseases.